GoodRx and Novo Nordisk teamed up to let people pay out-of-pocket for the new pill version of Ozempic (semaglutide) through GoodRx's discount platform. This makes the oral form easier to afford for patients who don't use insurance.

• •GoodRx and Novo Nordisk partnered on self-pay pricing for oral Ozempic
• •Deal targets patients paying out-of-pocket without insurance
• •Covers the pill version of semaglutide

GoodRx is making oral semaglutide (the pill form of Ozempic) more accessible to people paying out of pocket for type 2 diabetes treatment. The company is expanding its cash-pay options, likely through discounts or price negotiation.

• •GoodRx is expanding cash-pay access to oral semaglutide (pill form of Ozempic)
• •The program targets type 2 diabetes patients paying out of pocket

GoodRx, a discount pharmacy platform, is now helping patients access the pill version of Ozempic (semaglutide), Novo Nordisk's weight-loss and diabetes drug. The move makes the oral form easier to buy for people looking for cheaper options.

• •GoodRx now offers access to oral Ozempic (semaglutide)
• •The platform aims to lower costs for patients buying the pill
• •Novo Nordisk makes the oral semaglutide product

GoodRx, a discount drug website, now offers Rybelsus (the pill form of semaglutide) for people with type 2 diabetes. This expands access to Novo Nordisk's weight-loss and diabetes drug through a popular discount pharmacy platform.

• •GoodRx added Rybelsus, the pill form of semaglutide, to its discount platform
• •Offer targets type 2 diabetes patients
• •Rybelsus is made by Novo Nordisk